CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Rituximab
Related studies linked through entity extraction aliases.
Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)
- Status
- TERMINATED
- Phase
- PHASE3
Rituximab/Bendamustine + Rituximab/Cytarabine for Mantle Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
GA In NEwly Diagnosed Diffuse Large B Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Dinaciclib in Combination With Rituximab in Participants With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma (P07974)
- Status
- COMPLETED
- Phase
- PHASE1
A Phase 3 Open Label Randomized Study to Compare the Efficacy and Safety of Rituximab Plus Lenalidomide (CC-5013) Versus Rituximab Plus Chemotherapy Followed by Rituximab in Subjects With Previously Untreated Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Rheumatoid Arthritis and an Inadequate Response or Intolerance to One Anti-Tumor Necrosis Factor (Anti-TNF) Agent
- Status
- COMPLETED
- Phase
- N/A
Phase II Study of High-Dose Rituximab in High-Risk Chronic Lymphocytic Leukemia Patients in Suboptimal Response After Induction Immunochemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Valproate as First Line Therapy in Combination With Rituximab and CHOP in Diffuse Large B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
NK Cells in Cord Blood Transplantation
- Status
- UNKNOWN
- Phase
- PHASE1
An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
- Status
- COMPLETED
- Phase
- N/A
An Observational Study of MabThera in Participants With Severe Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- N/A
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
A Study of MabThera/Rituxan (Rituximab) Alone and in Combination With Roferon-A in Patients With Follicular or Other CD20+ Low-Grade (Indolent) Lymphoma
- Status
- COMPLETED
- Phase
- PHASE3
A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Low Dose Rituximab as a First Line Biologic Therapy for the Treatment of DMARD Resistant Patients With Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
Randomised Trial in Waldenstrom's Macroglobulinaemia
- Status
- COMPLETED
- Phase
- PHASE2
An Observational Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis And Inadequate Response Or Intolerance to a First Anti-TNF Alpha Therapy
- Status
- COMPLETED
- Phase
- N/A
Rituximab in IgG4-RD: A Phase 1-2 Trial
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2